News

Fathom Holdings Inc. Impresses with Q3 Growth and Insights

Fathom Holdings Inc. Impresses with Q3 Growth and Insights

Fathom Holdings' Exceptional Revenue Growth in Q3 2025

Fathom Holdings Inc. (NASDAQ: FTHM) has announced remarkable financial results for the third quarter, highlighting a significant year-over-year revenue increase of 38%. This notable achievement is largely attributed to a 23% increase in transactions and a 24% rise in the number of agents within the company. The adjusted EBITDA has achieved profitability for the second consecutive quarter, marking a significant milestone for the organization.

Leadership Insights into Performance

Marco Fregenal, CEO of Fathom Holdings, expressed his satisfaction with this quarter's results. He stated, "Despite facing challenges in the housing market, our ability to achieve 38% revenue growth and continued profitability in competitive conditions shows our strength and adaptability. We have expanded our agent base and made significant advancements across various initiatives on our platform."

Strong Operational Performance

Growth in Ancillary Services

Fathom's ancillary services are performing exceptionally well, particularly in the title revenue sector, which has grown by 29%. This success underscores Fathom's unique capability to provide complementary services, exemplified by the Elevate program, which is designed to equip agents with the tools necessary to enhance their productivity and profit margins effectively.

Strategic Initiatives and Future Plans

The company continues to pursue aggressive growth strategies. Recently, they expanded Verus Title into several new states while enhancing team capabilities through strategic hires. Additionally, in October, Fathom acquired START Real Estate, enabling the integration of a first-time homebuyer model with their proprietary technology, positioning them well for growth in underserved market segments.

Financial Highlights for Q3 2025

  • Fathom's total revenue witnessed an increase of 37.7%, totaling $115.3 million compared to $83.7 million in Q3 2024.
  • Brokerage revenue jumped 39% to $109.2 million, further highlighting growth in core service offerings.
  • Mortgage revenue rose 20.7% to $3.5 million, while title revenue increased by 28.6% to $1.8 million.
  • Gross profit surged by 39.1%, reaching $9.6 million for the quarter.
  • In September, Fathom executed a $6.9 million common stock offering, bolstering its financial foundation for future initiatives.

Operational Milestones

  • The number of licensed real estate agents affiliated with Fathom expanded by 24.1%, reaching approximately 15,371.
  • Real estate transactions grew 23%, totaling around 11,479 in Q3 2025.
  • 70 new agents were onboarded to the Elevate program, enhancing the training and development aspects of Fathom's offerings.
  • The expansion into Arizona and Alabama by Verus Title reflects Fathom’s intent to broaden its geographical footprint.
  • The integration of START Real Estate into Fathom’s operations represents a strong commitment to enhancing its service offerings.

Looking Ahead

Fathom Holdings aims to build upon this momentum, focusing on driving success for agents, increasing market penetration in key areas, and pursuing further growth through strategic partnerships and enhanced program offerings. The company is well-positioned to leverage anticipated improvements in housing market conditions to continue to generate substantial shareholder value in the upcoming quarters.

Frequently Asked Questions

What drove Fathom Holdings' revenue growth in Q3 2025?

The 38% revenue growth was primarily driven by a 23% increase in transactions and a 24% rise in agent count.

How is Fathom Holdings expanding its operations?

Fathom is expanding operations through acquisitions, strategic hires, and geographic expansion into new markets.

What initiatives is Fathom Holdings working on?

The company has launched programs like Elevate, designed to support agents and improve their transaction success.

What is the significance of adjusted EBITDA for Fathom Holdings?

Adjusted EBITDA indicates the company's operational profitability and is crucial for assessing cash flow performance.

How many agents does Fathom Holdings currently have?

Approximately 15,371 licensed agents are part of Fathom's network, reflecting a 24.1% growth on a year-over-year basis.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Etisalat Surges: Net Profit Soars 46% Amid Growth

Updated Category News Views 0

Etisalat's Stellar Performance: A Deeper Dive When a company like Etisalat drops news of a whopping 46% increase in net profit year-over-year, you sit up and pay attention. Those numbers aren’t just a flash in the pan; they're the result of some serious strategic maneuvers and ripe market conditions. Etisalat isn't resting on its laurels, and their latest financials...

Continue Reading
Backroads Invites Families: Adventures Boost Bookings by 20%

Updated Category News Views 8

Rediscovering Family Time Through Adventure When was the last time a winter vacation got you this fired up? Backroads, the trailblazer in active getaways, is bucking the trend of typical holiday madness. Families are ditching the usual gift-giving grind for something way more memorable: experiences that blend action with bonding across generations. Big Numbers, Big...

Continue Reading
Epilepsy Market's Explosive Growth Forecasted to 2036

Updated Category News Views 12

It's a wild world out there for epilepsy treatments—like a relentless bull run with everyone eyeing the prize. The latest buzz points to a fat 2036 forecast for this sector, driven by a mix of standout technologies and breakthrough therapies. You'd be a fool to blink and miss it. Rising Numbers Stir the Market The numbers, oh boy, they're climbing. In 2025, about 7...

Continue Reading
Antibiotic Overuse for Sinus Infections Costs Billions

Updated Category News Views 21

Sinus Infections: A Case of Excess Prescriptions You'd think with all the guidelines, doctors would've nailed the sinusitis treatment by now. But nope—antibiotic overuse remains alive and kicking. A fresh dig from Motive Medical Intelligence shows that more than three-quarters of primary care clinicians are quick to hand out antibiotics for acute sinusitis. So here we...

Continue Reading
Energy Fuels Secures Key Financing for Donald Project

Updated Category News Views 178

Donald Project: A Step Closer to Reality Look, when those rare earths start moving, the entire market gets a whiff of promise. Energy Fuels' Donald Rare Earth and Mineral Sands Project in Australia is gearing up for real action with a fresh funding nod. Export Finance Australia and the National Reconstruction Fund Corporation have conditionally greenlit up to A$180...

Continue Reading
Americans' Faith in Democracy Hits New Lows

Updated Category News Views 0

Polarization Beyond Politics: A National Reckoning When you catch wind of a report like this one, it's enough to make you feel like the fabric of democracy is unraveling right before our eyes. We're staring at a national identity crisis, folks, and it's got nothing to do with whether you're waving a red or blue flag. This ain't about party lines; it's about a bigger,...

Continue Reading
Pii's Odyssey Ignites Epic Cosmic Adventure

Updated Category News Views 113

A Cosmic Journey Begins Well, here's a fresh start to a galactic escapade or two! LaMont Schiers, with his brain teeming post a vivid dream, plunges headfirst into the science fiction scene. 'Pii's Odyssey: The Eternals' isn't your average bedtime read. Oh no, this is where a 14-year-old warrior kid named Pii gets yanked from his comfy home planet and tossed into a...

Continue Reading
Capacity LLC: Finalist in 2026 BeautyMatter Awards

Updated Category News Views 25

A Nod to Logistics and Beauty When beauty meets logistics, you end up with something like Capacity LLC making headlines in the 2026 BeautyMatter Awards. Now, I ain't one to usually get excited about anything involving freight and boxes, but this isn't just any nod in the 'Best Logistics Solution' category; it speaks volumes about where the beauty business is heading. Why...

Continue Reading
ALHC Faces Fraud Probe After 16% Stock Plummet

Updated Category News Views 28

Investors Eye Alignment's Tumultuous Turn One thing I don't do is sugarcoat it—stocks get hit hard sometimes, and Alignment Healthcare's recent saga has got jaws dropping across trading floors. It's only October, but Alignment's stock took a chilling nosedive on July 8, to the tune of 16.7%, leaving investors wide-eyed and demanding answers. What caused this seismic...

Continue Reading
Bladex Delivers Strong Q3 With $63M Net Profit

Updated Category News Views 63

Bladex Reports Impressive Q3 Profits Amid a sea of financial updates, Bladex's third-quarter numbers stand out like a lighthouse. They just flashed a $63.2 million net profit—up 15% from last year. That's the kind of growth that gets investors talking over their morning coffee. The magic behind these figures? Bladex managed to wrangle more revenue from net interest...

Continue Reading

Top 5 Most Recently Viewed Articles

Zenas BioPharma Class Action: Your Chance to Lead the Charge

Updated Category News Views 135

Opportunity to Lead Class Action Lawsuit for Zenas BioPharma Investors Investors of Zenas BioPharma, Inc. (NASDAQ: ZBIO) who have suffered substantial financial losses have a vital chance to become a lead plaintiff in an ongoing class action lawsuit. This opportunity stems from the registration statement connected to the company’s initial public offering (IPO)....

Continue Reading
Toyota Motor Adjusts EV Production Plans Amid Market Shifts

Updated Category News Views 173

Toyota Adjusts Its Production Strategies Toyota Motor Corporation (NYSE: TM) has recently faced a decline in its shares following the announcement of a major reduction in its electric vehicle production target for 2026. The company now aims to produce one million electric vehicles, which is a 30% decrease from its earlier forecast. This change is a response to a...

Continue Reading
Investors Urged to Explore Legal Options Against Fluence Energy

Updated Category News Views 363

Investors Encouraged to Take Action Against Fluence Energy Faruqi & Faruqi, LLP, a prominent national securities law firm, is actively investigating potential claims against Fluence Energy, Inc. (NASDAQ: FLNC). Recent market fluctuations have led to concerns that investors may have suffered significant financial losses. If you have incurred losses exceeding $75,000 in...

Continue Reading
Christopher A. DeNicola Takes Helm as CEO of Precision Spine

Updated Category News Views 215

Leadership Change at Precision Spine In a significant move, Precision Spine, Inc., a recognized leader in spinal pathology solutions, has announced the promotion of Christopher A. DeNicola to the role of President and Chief Executive Officer. This transition, which is effective immediately, places DeNicola in charge of guiding the company's strategic vision and...

Continue Reading
How Alliance Pharmaceuticals is Transforming Brand Protection

Updated Category News Views 120

Alliance Pharmaceuticals and TrueMed Forge New Partnership An innovative collaboration has emerged between Alliance Pharmaceuticals Ltd and TrueMed, aimed at tackling the ever-growing menace of counterfeit pharmaceuticals. This partnership leverages cutting-edge AI technology for efficient counterfeit detection, marking a significant shift in the operational landscape of...

Continue Reading